WO2026057073 - CLOSTRIDIUM SP. BACTERIUM AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/057073
Publication Date
19.03.2026
International Application No.
PCT/CN2025/121187
International Filing Date
13.09.2025
Title **
[English]
CLOSTRIDIUM SP. BACTERIUM AND USE THEREOF
[French]
BACTÉRIE CLOSTRIDIUM SP. ET SON UTILISATION
[Chinese]
一种梭菌属细菌及其应用
Applicants **
IBIOME BIOTECHNOLOGY CO., LTD.
Inventors
ZHU, Shu
TAO, Wanyin
SUN, Shanshan
ZHOU, Xu
JIA, Huiling
WEN, Wen
Priority Data
202411286805.7
13.09.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1575 | |
| EPO | Filing, Examination, Granting | 11611 | |
| Japan | Filing, Examination, Granting | 2014 | |
| South Korea | Filing, Examination, Granting | 1788 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,728
Contact Us
Abstract[English]
A Clostridium sp. bacterium and the use thereof. The bacterium can completely metabolize 2000μg/mL of uric acid in a culture medium within 8 hours. In vivo experiments show that the bacterium can significantly reduce the contents of uric acid in serum and urine of mice with hyperuricemia.[French]
La présente invention concerne une bactérie Clostridium sp. et son utilisation. La bactérie peut métaboliser complètement 2000 μg/mL d'acide urique dans un milieu de culture en 8 heures. Des expériences in vivo montrent que la bactérie peut réduire de manière significative les teneurs en acide urique dans le sérum et l'urine de souris présentant une hyperuricémie.[Chinese]
一种梭菌属（Clostridium sp.）细菌及其应用。该细菌能够在8小时内将培养基中约2000μg/mL的尿酸完全代谢。体内实验表明，该细菌可以使高尿酸血症小鼠的血清和尿液中的尿酸含量显著降低。